- Home
- SST vs ASRT Comparison
SST vs ASRT Comparison
Compare SST & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- ASRT
- Stock Information
- Founded
- SST 2013
- ASRT 1995
- Country
- SST United States
- ASRT United States
- Employees
- SST N/A
- ASRT N/A
- Industry
- SST Diversified Commercial Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- ASRT Health Care
- Exchange
- SST Nasdaq
- ASRT Nasdaq
- Market Cap
- SST 67.7M
- ASRT 78.2M
- IPO Year
- SST N/A
- ASRT 1997
- Fundamental
- Price
- SST $4.41
- ASRT $0.76
- Analyst Decision
- SST Strong Buy
- ASRT Strong Buy
- Analyst Count
- SST 1
- ASRT 1
- Target Price
- SST $10.00
- ASRT $3.00
- AVG Volume (30 Days)
- SST 24.1K
- ASRT 224.5K
- Earning Date
- SST 11-05-2025
- ASRT 11-10-2025
- Dividend Yield
- SST N/A
- ASRT N/A
- EPS Growth
- SST N/A
- ASRT N/A
- EPS
- SST N/A
- ASRT N/A
- Revenue
- SST $289,784,000.00
- ASRT $117,099,000.00
- Revenue This Year
- SST N/A
- ASRT N/A
- Revenue Next Year
- SST $12.20
- ASRT $4.10
- P/E Ratio
- SST N/A
- ASRT N/A
- Revenue Growth
- SST N/A
- ASRT N/A
- 52 Week Low
- SST $2.90
- ASRT $0.51
- 52 Week High
- SST $15.00
- ASRT $1.08
- Technical
- Relative Strength Index (RSI)
- SST 26.85
- ASRT 38.58
- Support Level
- SST $5.21
- ASRT $0.71
- Resistance Level
- SST $6.05
- ASRT $0.77
- Average True Range (ATR)
- SST 0.49
- ASRT 0.03
- MACD
- SST -0.13
- ASRT -0.01
- Stochastic Oscillator
- SST 1.06
- ASRT 35.16
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.